SCHEMBL11301393

SCHEMBL11301393

COC(=O)c1ccc(N(c2ccc3ncccc3c2)C2CCNC2=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ PLK1 P53350 1/20 0.42
▸ NPC1 O15118 4/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ HTR3A P46098 1/20 0.38
▸ TAS1R3 Q7RTX0 1/20 0.38
▸ TAS1R1 Q7RTX1 1/20 0.38
▸ POLB P06746 2/20 0.38
▸ HPGDS O60760 2/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ CYP3A4 P08684 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ DOT1L Q8TEK3 1/20 0.36
▸ OPRD1 P41143 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11296506 0.89 ALOX15 (0.44) ALOX15HTTNPC1RAB9AHPGDS
SCHEMBL11296058 0.83 MEN1 (0.47) HTTRAB9APOLBALDH1A1MEN1
SCHEMBL11296532 0.81 SLC6A3 (0.40) RAB9AALDH1A1MEN1MAPTKMT2A
SCHEMBL11295039 0.80 PSEN1 (0.40) KMT2AGAASMN1; SMN2
SCHEMBL11299441 0.76 MAPK14 (0.37) POLBMEN1MAPTKMT2AOPRD1
SCHEMBL11304336 0.74 HDAC6 (0.42) —
SCHEMBL30718649 0.74 ALOX15 (1.00) ALOX15HTTPLK1NPC1RAB9A
SCHEMBL265015 0.74 ALOX15 (1.00) ALOX15HTTPLK1NPC1RAB9A
SCHEMBL11296615 0.73 FLT1 (0.38) NPC1RAB9AMEN1MAPTKMT2A
SCHEMBL27928930 0.72 ALOX15 (0.97) ALOX15HTTPLK1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback